

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.70158065 |
| 2 | viral transcription (GO:0019083) | 6.12101578 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 5.87995970 |
| 4 | translational termination (GO:0006415) | 5.87895823 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.52640345 |
| 6 | cotranslational protein targeting to membrane (GO:0006613) | 5.41567945 |
| 7 | protein targeting to ER (GO:0045047) | 5.40275071 |
| 8 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.13363431 |
| 9 | protein localization to endoplasmic reticulum (GO:0070972) | 5.13135687 |
| 10 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.12265541 |
| 11 | chaperone-mediated protein transport (GO:0072321) | 5.08274726 |
| 12 | protein neddylation (GO:0045116) | 5.01158625 |
| 13 | translational elongation (GO:0006414) | 4.95040095 |
| 14 | DNA deamination (GO:0045006) | 4.65897479 |
| 15 | viral life cycle (GO:0019058) | 4.60482961 |
| 16 | maturation of SSU-rRNA (GO:0030490) | 4.52249632 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.36455599 |
| 18 | cellular protein complex disassembly (GO:0043624) | 4.35056439 |
| 19 | protein complex biogenesis (GO:0070271) | 4.29343579 |
| 20 | translational initiation (GO:0006413) | 4.17380077 |
| 21 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.99854268 |
| 22 | ATP biosynthetic process (GO:0006754) | 3.85359927 |
| 23 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.79217316 |
| 24 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.79217316 |
| 25 | ribosomal large subunit biogenesis (GO:0042273) | 3.78940060 |
| 26 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.77823463 |
| 27 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.75366758 |
| 28 | protein complex disassembly (GO:0043241) | 3.67646271 |
| 29 | translation (GO:0006412) | 3.60346383 |
| 30 | protein targeting to mitochondrion (GO:0006626) | 3.58826566 |
| 31 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.53947054 |
| 32 | protein targeting to membrane (GO:0006612) | 3.51387623 |
| 33 | regulation of mitochondrial translation (GO:0070129) | 3.49045999 |
| 34 | macromolecular complex disassembly (GO:0032984) | 3.42492102 |
| 35 | hydrogen ion transmembrane transport (GO:1902600) | 3.42286258 |
| 36 | positive regulation of ligase activity (GO:0051351) | 3.39549640 |
| 37 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.37483901 |
| 38 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.36349587 |
| 39 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.33519153 |
| 40 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.33255726 |
| 41 | protein localization to mitochondrion (GO:0070585) | 3.32462655 |
| 42 | establishment of protein localization to mitochondrion (GO:0072655) | 3.29876758 |
| 43 | spliceosomal snRNP assembly (GO:0000387) | 3.23212013 |
| 44 | cullin deneddylation (GO:0010388) | 3.21688235 |
| 45 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.20100235 |
| 46 | proteasome assembly (GO:0043248) | 3.18511000 |
| 47 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.18433530 |
| 48 | cytochrome complex assembly (GO:0017004) | 3.18168372 |
| 49 | rRNA modification (GO:0000154) | 3.15999673 |
| 50 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.11093591 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.10359750 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.07116122 |
| 53 | ATP synthesis coupled proton transport (GO:0015986) | 3.06613565 |
| 54 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.06613565 |
| 55 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.06548427 |
| 56 | mitochondrial transport (GO:0006839) | 3.06213194 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 3.05957141 |
| 58 | mRNA catabolic process (GO:0006402) | 3.05906186 |
| 59 | positive regulation of cell cycle arrest (GO:0071158) | 3.05107810 |
| 60 | deoxyribonucleotide catabolic process (GO:0009264) | 3.04123250 |
| 61 | establishment of integrated proviral latency (GO:0075713) | 3.03973456 |
| 62 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.03946301 |
| 63 | deoxyribose phosphate catabolic process (GO:0046386) | 3.02280817 |
| 64 | protein deneddylation (GO:0000338) | 3.01395816 |
| 65 | regulation of ligase activity (GO:0051340) | 3.00851559 |
| 66 | proton transport (GO:0015992) | 3.00676309 |
| 67 | signal peptide processing (GO:0006465) | 2.99617674 |
| 68 | response to interferon-beta (GO:0035456) | 2.98147193 |
| 69 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.98054383 |
| 70 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.98054383 |
| 71 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.94798611 |
| 72 | hydrogen transport (GO:0006818) | 2.94283086 |
| 73 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.93884382 |
| 74 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.93870299 |
| 75 | RNA catabolic process (GO:0006401) | 2.82472069 |
| 76 | telomere maintenance via recombination (GO:0000722) | 2.77922399 |
| 77 | GTP biosynthetic process (GO:0006183) | 2.76796332 |
| 78 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.70381037 |
| 79 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.70308433 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.62600371 |
| 81 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.62000452 |
| 82 | DNA strand elongation (GO:0022616) | 2.60733334 |
| 83 | platelet dense granule organization (GO:0060155) | 2.56156835 |
| 84 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.55742897 |
| 85 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.55742897 |
| 86 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.55667089 |
| 87 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.52622875 |
| 88 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.52622875 |
| 89 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.52622875 |
| 90 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.48608444 |
| 91 | formation of translation preinitiation complex (GO:0001731) | 2.48034651 |
| 92 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.44954232 |
| 93 | UTP biosynthetic process (GO:0006228) | 2.44624751 |
| 94 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.43669525 |
| 95 | negative regulation of ligase activity (GO:0051352) | 2.43669525 |
| 96 | rRNA processing (GO:0006364) | 2.43403979 |
| 97 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.42349809 |
| 98 | cellular component biogenesis (GO:0044085) | 2.42203948 |
| 99 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.42092677 |
| 100 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.41817000 |
| 101 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.40155615 |
| 102 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.40155615 |
| 103 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.37058165 |
| 104 | mitotic recombination (GO:0006312) | 2.36133119 |
| 105 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.35287922 |
| 106 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.35112128 |
| 107 | CENP-A containing nucleosome assembly (GO:0034080) | 2.34464928 |
| 108 | oxidative phosphorylation (GO:0006119) | 2.33628106 |
| 109 | rRNA metabolic process (GO:0016072) | 2.32507088 |
| 110 | regulation of metalloenzyme activity (GO:0048552) | 2.32249498 |
| 111 | establishment of protein localization to membrane (GO:0090150) | 2.32020730 |
| 112 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.29763568 |
| 113 | termination of RNA polymerase III transcription (GO:0006386) | 2.28908544 |
| 114 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.28908544 |
| 115 | UTP metabolic process (GO:0046051) | 2.28689545 |
| 116 | respiratory electron transport chain (GO:0022904) | 2.25197701 |
| 117 | CTP biosynthetic process (GO:0006241) | 2.24895215 |
| 118 | CTP metabolic process (GO:0046036) | 2.24895215 |
| 119 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.24580107 |
| 120 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.23127365 |
| 121 | electron transport chain (GO:0022900) | 2.20805874 |
| 122 | chromatin remodeling at centromere (GO:0031055) | 2.20269803 |
| 123 | protein targeting (GO:0006605) | 2.17463626 |
| 124 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.17081513 |
| 125 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.15551648 |
| 126 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.15550440 |
| 127 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.14970093 |
| 128 | NADH dehydrogenase complex assembly (GO:0010257) | 2.14970093 |
| 129 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.14970093 |
| 130 | respiratory chain complex IV assembly (GO:0008535) | 2.14953727 |
| 131 | purine-containing compound salvage (GO:0043101) | 2.13931579 |
| 132 | daunorubicin metabolic process (GO:0044597) | 2.12741957 |
| 133 | polyketide metabolic process (GO:0030638) | 2.12741957 |
| 134 | doxorubicin metabolic process (GO:0044598) | 2.12741957 |
| 135 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.12580014 |
| 136 | aldehyde catabolic process (GO:0046185) | 2.11802526 |
| 137 | cellular response to interferon-beta (GO:0035458) | 2.09980815 |
| 138 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.08488414 |
| 139 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.08442187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.80307762 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.64350141 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.53754572 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.37163601 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.26893898 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.19553266 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.02018040 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.94697016 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.82566360 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.80634787 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.62300635 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.60516475 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.52301265 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.45418464 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.43915833 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.41974282 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.31340837 |
| 18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.28842586 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26744998 |
| 20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.15479439 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09476893 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.06917370 |
| 23 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.06809996 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.04305778 |
| 25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02250495 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.01189325 |
| 27 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.00185941 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98003864 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.95895561 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.93929513 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92084574 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89510183 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88987812 |
| 34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.88516458 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88154384 |
| 36 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.87978372 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87975876 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.86917792 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.85698631 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.84578339 |
| 41 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.79402956 |
| 42 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74097968 |
| 43 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.70242478 |
| 44 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.60914971 |
| 45 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.58612954 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.53766154 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.53207233 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.51441239 |
| 49 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49597519 |
| 50 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.48110435 |
| 51 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.47252816 |
| 52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43398463 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41770237 |
| 54 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.41409509 |
| 55 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40139772 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.38354062 |
| 57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36450097 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36012851 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34762948 |
| 60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33406625 |
| 61 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.30400057 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29242375 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26261257 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23765905 |
| 65 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22686213 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21721687 |
| 67 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20826965 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.19883932 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16488823 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16089868 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15801712 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15691714 |
| 73 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14685549 |
| 74 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13923686 |
| 75 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13345386 |
| 76 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.12951566 |
| 77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.10523415 |
| 78 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.08520117 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07228472 |
| 80 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06928442 |
| 81 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05816663 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02305301 |
| 83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01724796 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01465425 |
| 85 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98942823 |
| 86 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.97978870 |
| 87 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97555975 |
| 88 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.97437985 |
| 89 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96827259 |
| 90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95661062 |
| 91 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95152777 |
| 92 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.95025318 |
| 93 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94908986 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.94263315 |
| 95 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93805300 |
| 96 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93120532 |
| 97 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92194823 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.92030145 |
| 99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91933149 |
| 100 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91523169 |
| 101 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91497693 |
| 102 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.90844875 |
| 103 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90561736 |
| 104 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90159307 |
| 105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.89775837 |
| 106 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88804729 |
| 107 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87961944 |
| 108 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87938783 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86949739 |
| 110 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86252622 |
| 111 | * MYB_26560356_Chip-Seq_TH2_Human | 0.86157760 |
| 112 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85046062 |
| 113 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.84861847 |
| 114 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83889633 |
| 115 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.83326203 |
| 116 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82801520 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.82450528 |
| 118 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.80263678 |
| 119 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.77754581 |
| 120 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77524441 |
| 121 | VDR_22108803_ChIP-Seq_LS180_Human | 0.76512802 |
| 122 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.75384867 |
| 123 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.74011121 |
| 124 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.73604325 |
| 125 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.73599422 |
| 126 | EWS_26573619_Chip-Seq_HEK293_Human | 0.73134771 |
| 127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72707933 |
| 128 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.72194983 |
| 129 | AR_20517297_ChIP-Seq_VCAP_Human | 0.72176677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 2.98663854 |
| 2 | MP0006292_abnormal_olfactory_placode | 2.85877143 |
| 3 | MP0003186_abnormal_redox_activity | 2.63383276 |
| 4 | MP0008789_abnormal_olfactory_epithelium | 2.61427937 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.55345022 |
| 6 | MP0009785_altered_susceptibility_to | 2.47596960 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.43384175 |
| 8 | MP0003724_increased_susceptibility_to | 2.29641784 |
| 9 | MP0003436_decreased_susceptibility_to | 2.14255890 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.04070371 |
| 11 | MP0001853_heart_inflammation | 1.97548636 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 1.93149897 |
| 13 | MP0006072_abnormal_retinal_apoptosis | 1.90804337 |
| 14 | MP0000685_abnormal_immune_system | 1.83310475 |
| 15 | MP0005025_abnormal_response_to | 1.82028543 |
| 16 | MP0002163_abnormal_gland_morphology | 1.78533172 |
| 17 | MP0001529_abnormal_vocalization | 1.78473993 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 1.70467336 |
| 19 | MP0002132_abnormal_respiratory_system | 1.68254021 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.67164335 |
| 21 | MP0003718_maternal_effect | 1.63296548 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 1.63146544 |
| 23 | MP0002419_abnormal_innate_immunity | 1.62962546 |
| 24 | MP0005671_abnormal_response_to | 1.59774984 |
| 25 | MP0006054_spinal_hemorrhage | 1.59613714 |
| 26 | MP0005394_taste/olfaction_phenotype | 1.57545869 |
| 27 | MP0005499_abnormal_olfactory_system | 1.57545869 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.53833182 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.52867696 |
| 30 | MP0000490_abnormal_crypts_of | 1.52508398 |
| 31 | MP0006035_abnormal_mitochondrial_morpho | 1.51898717 |
| 32 | MP0001293_anophthalmia | 1.51504701 |
| 33 | MP0004147_increased_porphyrin_level | 1.47959077 |
| 34 | MP0008007_abnormal_cellular_replicative | 1.46117345 |
| 35 | MP0002405_respiratory_system_inflammati | 1.45565585 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.42956028 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.41817836 |
| 38 | MP0000343_altered_response_to | 1.39183684 |
| 39 | MP0005408_hypopigmentation | 1.37056956 |
| 40 | MP0001879_abnormal_lymphatic_vessel | 1.35258681 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.34573116 |
| 42 | MP0002723_abnormal_immune_serum | 1.33632436 |
| 43 | MP0003077_abnormal_cell_cycle | 1.30725155 |
| 44 | MP0002006_tumorigenesis | 1.29894593 |
| 45 | MP0003011_delayed_dark_adaptation | 1.29783643 |
| 46 | MP0006082_CNS_inflammation | 1.29767569 |
| 47 | MP0001800_abnormal_humoral_immune | 1.29317725 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.29237245 |
| 49 | MP0001819_abnormal_immune_cell | 1.28695174 |
| 50 | MP0005367_renal/urinary_system_phenotyp | 1.28691926 |
| 51 | MP0000516_abnormal_urinary_system | 1.28691926 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.28503683 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.27030164 |
| 54 | MP0005387_immune_system_phenotype | 1.24097767 |
| 55 | MP0001790_abnormal_immune_system | 1.24097767 |
| 56 | MP0002938_white_spotting | 1.22017756 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.21657970 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.21657970 |
| 59 | MP0002090_abnormal_vision | 1.19116059 |
| 60 | MP0008995_early_reproductive_senescence | 1.18508831 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.16931267 |
| 62 | MP0008469_abnormal_protein_level | 1.16883838 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.16620210 |
| 64 | MP0008932_abnormal_embryonic_tissue | 1.15824526 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.14683372 |
| 66 | MP0003136_yellow_coat_color | 1.14595454 |
| 67 | MP0010368_abnormal_lymphatic_system | 1.13984936 |
| 68 | MP0000858_altered_metastatic_potential | 1.13229125 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.13033379 |
| 70 | MP0000372_irregular_coat_pigmentation | 1.12428291 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.10282652 |
| 72 | MP0002933_joint_inflammation | 1.10228419 |
| 73 | MP0009764_decreased_sensitivity_to | 1.06506909 |
| 74 | MP0002398_abnormal_bone_marrow | 1.04248956 |
| 75 | MP0002234_abnormal_pharynx_morphology | 1.04154659 |
| 76 | MP0003195_calcinosis | 1.03711804 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 1.03041950 |
| 78 | MP0000689_abnormal_spleen_morphology | 1.03024845 |
| 79 | MP0000716_abnormal_immune_system | 1.03012387 |
| 80 | MP0009697_abnormal_copulation | 1.02946858 |
| 81 | MP0003828_pulmonary_edema | 1.01774458 |
| 82 | MP0002722_abnormal_immune_system | 1.01620828 |
| 83 | MP0000358_abnormal_cell_content/ | 1.00997393 |
| 84 | MP0002429_abnormal_blood_cell | 1.00725263 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 1.00294130 |
| 86 | MP0002102_abnormal_ear_morphology | 1.00086532 |
| 87 | MP0010094_abnormal_chromosome_stability | 0.99147337 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.98410925 |
| 89 | MP0001542_abnormal_bone_strength | 0.97707136 |
| 90 | MP0008875_abnormal_xenobiotic_pharmacok | 0.97325703 |
| 91 | MP0005253_abnormal_eye_physiology | 0.95896313 |
| 92 | MP0001873_stomach_inflammation | 0.95874051 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.95676938 |
| 94 | MP0001727_abnormal_embryo_implantation | 0.94648966 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.94515423 |
| 96 | MP0005023_abnormal_wound_healing | 0.93592279 |
| 97 | MP0010030_abnormal_orbit_morphology | 0.93210460 |
| 98 | MP0003941_abnormal_skin_development | 0.92790543 |
| 99 | MP0003786_premature_aging | 0.91216082 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 0.90961776 |
| 101 | MP0005332_abnormal_amino_acid | 0.88601391 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.87452676 |
| 103 | MP0003646_muscle_fatigue | 0.86992128 |
| 104 | MP0004381_abnormal_hair_follicle | 0.86110046 |
| 105 | MP0002282_abnormal_trachea_morphology | 0.85556316 |
| 106 | MP0006036_abnormal_mitochondrial_physio | 0.82852279 |
| 107 | MP0002098_abnormal_vibrissa_morphology | 0.82032151 |
| 108 | MP0005390_skeleton_phenotype | 0.81640185 |
| 109 | MP0002138_abnormal_hepatobiliary_system | 0.81115002 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.80753950 |
| 111 | MP0000313_abnormal_cell_death | 0.79494675 |
| 112 | MP0003279_aneurysm | 0.79308250 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.78906830 |
| 114 | MP0004142_abnormal_muscle_tone | 0.78885302 |
| 115 | MP0008057_abnormal_DNA_replication | 0.77872998 |
| 116 | MP0002139_abnormal_hepatobiliary_system | 0.77456225 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.77203278 |
| 118 | MP0005330_cardiomyopathy | 0.77164275 |
| 119 | MP0002019_abnormal_tumor_incidence | 0.76468441 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.76019720 |
| 121 | MP0004019_abnormal_vitamin_homeostasis | 0.75101228 |
| 122 | MP0005451_abnormal_body_composition | 0.74462526 |
| 123 | MP0004947_skin_inflammation | 0.74348653 |
| 124 | MP0005085_abnormal_gallbladder_physiolo | 0.73819879 |
| 125 | MP0000749_muscle_degeneration | 0.72936830 |
| 126 | MP0008058_abnormal_DNA_repair | 0.71431174 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.70978821 |
| 128 | MP0002210_abnormal_sex_determination | 0.70843805 |
| 129 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70599003 |
| 130 | MP0003315_abnormal_perineum_morphology | 0.70148668 |
| 131 | MP0001905_abnormal_dopamine_level | 0.70132588 |
| 132 | MP0003448_altered_tumor_morphology | 0.69954704 |
| 133 | MP0000049_abnormal_middle_ear | 0.69918658 |
| 134 | MP0001764_abnormal_homeostasis | 0.69837894 |
| 135 | MP0009643_abnormal_urine_homeostasis | 0.68969614 |
| 136 | MP0005083_abnormal_biliary_tract | 0.68542789 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.68349727 |
| 138 | MP0001881_abnormal_mammary_gland | 0.68311741 |
| 139 | MP0009763_increased_sensitivity_to | 0.68103234 |
| 140 | MP0005058_abnormal_lysosome_morphology | 0.67711264 |
| 141 | MP0003111_abnormal_nucleus_morphology | 0.66880033 |
| 142 | MP0005165_increased_susceptibility_to | 0.66503663 |
| 143 | MP0004133_heterotaxia | 0.64864208 |
| 144 | MP0005389_reproductive_system_phenotype | 0.64636056 |
| 145 | MP0002233_abnormal_nose_morphology | 0.63769408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.40740681 |
| 2 | Reticulocytopenia (HP:0001896) | 5.11367472 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.04124192 |
| 4 | Macrocytic anemia (HP:0001972) | 3.51658787 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.36199632 |
| 6 | Pallor (HP:0000980) | 3.34870819 |
| 7 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.34756993 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 2.93483711 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.92247289 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.92247289 |
| 11 | Increased serum pyruvate (HP:0003542) | 2.90816835 |
| 12 | Leukodystrophy (HP:0002415) | 2.85227198 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 2.84639988 |
| 14 | Reduced antithrombin III activity (HP:0001976) | 2.83880409 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 2.82482704 |
| 16 | 11 pairs of ribs (HP:0000878) | 2.81564594 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 2.81499865 |
| 18 | Exertional dyspnea (HP:0002875) | 2.79449772 |
| 19 | Aplastic anemia (HP:0001915) | 2.77819834 |
| 20 | Mitochondrial inheritance (HP:0001427) | 2.77566301 |
| 21 | Degeneration of anterior horn cells (HP:0002398) | 2.75602656 |
| 22 | Abnormality of the anterior horn cell (HP:0006802) | 2.75602656 |
| 23 | Optic disc pallor (HP:0000543) | 2.75462660 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74864021 |
| 25 | Lipid accumulation in hepatocytes (HP:0006561) | 2.73239462 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.62839611 |
| 27 | Hepatic necrosis (HP:0002605) | 2.62065829 |
| 28 | Lethargy (HP:0001254) | 2.61710375 |
| 29 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.60811512 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.59400709 |
| 31 | Petechiae (HP:0000967) | 2.54835377 |
| 32 | Hyperglycinemia (HP:0002154) | 2.52127752 |
| 33 | Thrombocytosis (HP:0001894) | 2.51842055 |
| 34 | Acute encephalopathy (HP:0006846) | 2.41546918 |
| 35 | Eczematoid dermatitis (HP:0000976) | 2.40458145 |
| 36 | Microvesicular hepatic steatosis (HP:0001414) | 2.39609841 |
| 37 | Hepatocellular necrosis (HP:0001404) | 2.39483974 |
| 38 | CNS demyelination (HP:0007305) | 2.37742142 |
| 39 | Abnormality of glycolysis (HP:0004366) | 2.37548313 |
| 40 | Poor head control (HP:0002421) | 2.36060317 |
| 41 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.34684256 |
| 42 | Congenital, generalized hypertrichosis (HP:0004540) | 2.32809458 |
| 43 | 3-Methylglutaconic aciduria (HP:0003535) | 2.31545532 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.29090047 |
| 45 | Increased CSF lactate (HP:0002490) | 2.28936111 |
| 46 | Abnormal hemoglobin (HP:0011902) | 2.23006323 |
| 47 | Increased intramyocellular lipid droplets (HP:0012240) | 2.22676749 |
| 48 | Nausea (HP:0002018) | 2.22587248 |
| 49 | Abnormality of secondary sexual hair (HP:0009888) | 2.21509953 |
| 50 | Abnormality of the axillary hair (HP:0100134) | 2.21509953 |
| 51 | Exercise intolerance (HP:0003546) | 2.19749730 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.18595151 |
| 53 | Progressive macrocephaly (HP:0004481) | 2.16354332 |
| 54 | X-linked dominant inheritance (HP:0001423) | 2.16016724 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.14765904 |
| 56 | Increased muscle lipid content (HP:0009058) | 2.12135713 |
| 57 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.11185392 |
| 58 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.11185392 |
| 59 | Abnormal protein glycosylation (HP:0012346) | 2.11185392 |
| 60 | Abnormal glycosylation (HP:0012345) | 2.11185392 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.06769639 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06527645 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05247327 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.05247327 |
| 65 | Myositis (HP:0100614) | 2.03625097 |
| 66 | Methylmalonic acidemia (HP:0002912) | 2.02740287 |
| 67 | Methylmalonic aciduria (HP:0012120) | 2.02358936 |
| 68 | Molar tooth sign on MRI (HP:0002419) | 1.98876462 |
| 69 | Abnormality of midbrain morphology (HP:0002418) | 1.98876462 |
| 70 | Emotional lability (HP:0000712) | 1.96607988 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 1.96463717 |
| 72 | Glycosuria (HP:0003076) | 1.90364169 |
| 73 | Abnormality of urine glucose concentration (HP:0011016) | 1.90364169 |
| 74 | IgM deficiency (HP:0002850) | 1.89577486 |
| 75 | Cleft eyelid (HP:0000625) | 1.89480469 |
| 76 | Respiratory difficulties (HP:0002880) | 1.86685479 |
| 77 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.85355776 |
| 78 | True hermaphroditism (HP:0010459) | 1.81436411 |
| 79 | Cerebral edema (HP:0002181) | 1.81173658 |
| 80 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80170150 |
| 81 | Microretrognathia (HP:0000308) | 1.80146750 |
| 82 | Sparse eyelashes (HP:0000653) | 1.79353533 |
| 83 | Respiratory failure (HP:0002878) | 1.78792839 |
| 84 | Multiple enchondromatosis (HP:0005701) | 1.77768485 |
| 85 | Muscle fiber atrophy (HP:0100295) | 1.77668924 |
| 86 | Oral leukoplakia (HP:0002745) | 1.76233392 |
| 87 | Pancreatic fibrosis (HP:0100732) | 1.76177367 |
| 88 | Median cleft lip (HP:0000161) | 1.75850884 |
| 89 | Pancreatic cysts (HP:0001737) | 1.75651653 |
| 90 | Increased serum lactate (HP:0002151) | 1.75188339 |
| 91 | Colon cancer (HP:0003003) | 1.75169308 |
| 92 | Abnormality of reticulocytes (HP:0004312) | 1.75096728 |
| 93 | Sclerocornea (HP:0000647) | 1.74699862 |
| 94 | Abnormality of alanine metabolism (HP:0010916) | 1.73892123 |
| 95 | Hyperalaninemia (HP:0003348) | 1.73892123 |
| 96 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73892123 |
| 97 | Blindness (HP:0000618) | 1.73456291 |
| 98 | Metaphyseal dysplasia (HP:0100255) | 1.73002921 |
| 99 | Recurrent skin infections (HP:0001581) | 1.72521593 |
| 100 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.71547886 |
| 101 | Abnormality of methionine metabolism (HP:0010901) | 1.69510782 |
| 102 | Vomiting (HP:0002013) | 1.67529620 |
| 103 | Hepatosplenomegaly (HP:0001433) | 1.67107836 |
| 104 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67063629 |
| 105 | Partial duplication of thumb phalanx (HP:0009944) | 1.65235953 |
| 106 | Palpitations (HP:0001962) | 1.64819392 |
| 107 | Carpal bone hypoplasia (HP:0001498) | 1.64020285 |
| 108 | Abnormality of T cell physiology (HP:0011840) | 1.63959382 |
| 109 | Abnormality of renal resorption (HP:0011038) | 1.63818436 |
| 110 | Medial flaring of the eyebrow (HP:0010747) | 1.62460140 |
| 111 | Pustule (HP:0200039) | 1.61949750 |
| 112 | Increased IgM level (HP:0003496) | 1.61383652 |
| 113 | Parakeratosis (HP:0001036) | 1.59209432 |
| 114 | Rough bone trabeculation (HP:0100670) | 1.58631612 |
| 115 | Hyperglycinuria (HP:0003108) | 1.58169871 |
| 116 | Lactic acidosis (HP:0003128) | 1.57503125 |
| 117 | Autoimmune thrombocytopenia (HP:0001973) | 1.56717184 |
| 118 | Orchitis (HP:0100796) | 1.55794594 |
| 119 | Abnormality of glycine metabolism (HP:0010895) | 1.55629281 |
| 120 | Pulmonary artery stenosis (HP:0004415) | 1.54772233 |
| 121 | Trismus (HP:0000211) | 1.53333913 |
| 122 | Hypoglycemic coma (HP:0001325) | 1.53249309 |
| 123 | Chronic obstructive pulmonary disease (HP:0006510) | 1.52368788 |
| 124 | Obstructive lung disease (HP:0006536) | 1.52368788 |
| 125 | Pancytopenia (HP:0001876) | 1.51562064 |
| 126 | Stenosis of the external auditory canal (HP:0000402) | 1.51249960 |
| 127 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.51157431 |
| 128 | Urticaria (HP:0001025) | 1.50309236 |
| 129 | Partial duplication of the phalanx of hand (HP:0009999) | 1.49517597 |
| 130 | Abnormality of the columella (HP:0009929) | 1.48641363 |
| 131 | Rhabdomyolysis (HP:0003201) | 1.48634553 |
| 132 | Abnormality of placental membranes (HP:0011409) | 1.47490925 |
| 133 | Amniotic constriction ring (HP:0009775) | 1.47490925 |
| 134 | Hyperphosphaturia (HP:0003109) | 1.47303565 |
| 135 | Beaking of vertebral bodies (HP:0004568) | 1.47051893 |
| 136 | Autoimmune hemolytic anemia (HP:0001890) | 1.45985205 |
| 137 | Irregular epiphyses (HP:0010582) | 1.45575573 |
| 138 | Proximal tubulopathy (HP:0000114) | 1.45218737 |
| 139 | Absent thumb (HP:0009777) | 1.44825693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.99727057 |
| 2 | NME2 | 4.06436391 |
| 3 | NEK1 | 2.93539344 |
| 4 | PBK | 2.85706820 |
| 5 | PIM2 | 2.64326415 |
| 6 | MAP3K12 | 2.51788101 |
| 7 | STK16 | 2.38260404 |
| 8 | KDR | 2.35452098 |
| 9 | WEE1 | 2.21703125 |
| 10 | MST4 | 2.14261155 |
| 11 | EIF2AK3 | 2.13772815 |
| 12 | BUB1 | 2.07692097 |
| 13 | EIF2AK1 | 1.98190676 |
| 14 | VRK1 | 1.95384217 |
| 15 | ACVR1B | 1.81810060 |
| 16 | IRAK4 | 1.72227844 |
| 17 | CDK19 | 1.70999386 |
| 18 | TEC | 1.69944383 |
| 19 | OBSCN | 1.53466091 |
| 20 | MYLK | 1.52815988 |
| 21 | TRIM28 | 1.52543199 |
| 22 | TESK1 | 1.49597856 |
| 23 | IRAK3 | 1.48818656 |
| 24 | TBK1 | 1.48017866 |
| 25 | MKNK1 | 1.46873520 |
| 26 | LRRK2 | 1.43839808 |
| 27 | BLK | 1.42652308 |
| 28 | PDK2 | 1.42538640 |
| 29 | RPS6KA4 | 1.39730970 |
| 30 | NME1 | 1.38739173 |
| 31 | BRSK2 | 1.36550979 |
| 32 | IKBKB | 1.33678956 |
| 33 | MAP4K2 | 1.31848839 |
| 34 | NLK | 1.31178836 |
| 35 | PLK4 | 1.31092314 |
| 36 | BTK | 1.30213802 |
| 37 | BCKDK | 1.28595208 |
| 38 | PLK3 | 1.26883517 |
| 39 | MAP3K14 | 1.25536699 |
| 40 | MAP3K3 | 1.25466614 |
| 41 | MAP3K11 | 1.24112502 |
| 42 | ZAK | 1.23995199 |
| 43 | KIT | 1.23408289 |
| 44 | TYK2 | 1.23072862 |
| 45 | PIK3CG | 1.20083789 |
| 46 | RPS6KB2 | 1.19555760 |
| 47 | TESK2 | 1.18804280 |
| 48 | TGFBR1 | 1.17620428 |
| 49 | MAP4K1 | 1.16834796 |
| 50 | DYRK3 | 1.16254687 |
| 51 | MAP2K3 | 1.13566653 |
| 52 | TIE1 | 1.13310502 |
| 53 | TLK1 | 1.12436158 |
| 54 | MUSK | 1.12007767 |
| 55 | CCNB1 | 1.11416816 |
| 56 | ABL2 | 1.10389236 |
| 57 | MAPK15 | 1.08752371 |
| 58 | IKBKE | 1.08199199 |
| 59 | DYRK2 | 1.07931704 |
| 60 | STK10 | 1.07797011 |
| 61 | SRPK1 | 1.07659177 |
| 62 | EIF2AK2 | 1.06864784 |
| 63 | JAK3 | 1.05657001 |
| 64 | CSNK1G3 | 1.05181181 |
| 65 | PIM1 | 1.02990249 |
| 66 | FLT3 | 1.01713990 |
| 67 | ERN1 | 0.96875964 |
| 68 | TXK | 0.96093030 |
| 69 | NEK9 | 0.94912497 |
| 70 | ARAF | 0.93225766 |
| 71 | TTK | 0.92962757 |
| 72 | AURKB | 0.92721372 |
| 73 | DAPK3 | 0.91451594 |
| 74 | STK4 | 0.91410666 |
| 75 | LIMK1 | 0.88683253 |
| 76 | TAF1 | 0.87735253 |
| 77 | BMPR2 | 0.86672472 |
| 78 | WNK3 | 0.86092665 |
| 79 | CDK7 | 0.85393046 |
| 80 | ILK | 0.84348182 |
| 81 | BCR | 0.84095698 |
| 82 | CSNK1G1 | 0.79506979 |
| 83 | CDK8 | 0.79035806 |
| 84 | STK24 | 0.77383630 |
| 85 | ZAP70 | 0.76913161 |
| 86 | TGFBR2 | 0.76836470 |
| 87 | PRKG2 | 0.75494137 |
| 88 | PAK4 | 0.75312659 |
| 89 | NUAK1 | 0.74419373 |
| 90 | RPS6KA5 | 0.73192192 |
| 91 | GRK7 | 0.73008903 |
| 92 | CHEK2 | 0.71266426 |
| 93 | LYN | 0.71234035 |
| 94 | TRPM7 | 0.71168612 |
| 95 | CSNK1G2 | 0.70961793 |
| 96 | CSNK1A1L | 0.70860039 |
| 97 | EPHB2 | 0.68603209 |
| 98 | MAP2K2 | 0.67911270 |
| 99 | CSNK2A2 | 0.67484260 |
| 100 | BMPR1B | 0.65906445 |
| 101 | MAP3K8 | 0.64947403 |
| 102 | SIK3 | 0.64658669 |
| 103 | DAPK1 | 0.62701874 |
| 104 | PASK | 0.61061639 |
| 105 | ERBB3 | 0.60506262 |
| 106 | CHUK | 0.59648595 |
| 107 | MOS | 0.59479913 |
| 108 | MKNK2 | 0.57891726 |
| 109 | CSNK2A1 | 0.57060207 |
| 110 | PIK3CA | 0.56753988 |
| 111 | ATR | 0.56161956 |
| 112 | YES1 | 0.55146979 |
| 113 | GRK1 | 0.52530564 |
| 114 | MAPKAPK5 | 0.52327061 |
| 115 | WNK4 | 0.52316062 |
| 116 | PLK1 | 0.51708631 |
| 117 | MATK | 0.50696558 |
| 118 | CLK1 | 0.50067282 |
| 119 | DYRK1B | 0.49694831 |
| 120 | IRAK1 | 0.48332300 |
| 121 | BRSK1 | 0.48181502 |
| 122 | NEK2 | 0.48168582 |
| 123 | ADRBK2 | 0.47959310 |
| 124 | MAPKAPK2 | 0.46985857 |
| 125 | PAK1 | 0.46945183 |
| 126 | MAPKAPK3 | 0.46614249 |
| 127 | TAOK2 | 0.45882691 |
| 128 | STK39 | 0.42235226 |
| 129 | LCK | 0.41932775 |
| 130 | CDC7 | 0.41641720 |
| 131 | EPHA2 | 0.41603473 |
| 132 | AURKA | 0.41167664 |
| 133 | TNIK | 0.40505352 |
| 134 | BRAF | 0.36167010 |
| 135 | PLK2 | 0.32200638 |
| 136 | OXSR1 | 0.30324760 |
| 137 | CSF1R | 0.28947674 |
| 138 | DMPK | 0.28412867 |
| 139 | CDK14 | 0.27758238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.16702218 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.24133197 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.91329808 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.77767063 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.31927426 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.28971293 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.11104688 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.06831336 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.01393210 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.97019193 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 1.95557030 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 1.83721184 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.69750891 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.60288387 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.54233247 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.47709333 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.43812295 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33449741 |
| 19 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.30365192 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28436607 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26814242 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.26036464 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.24824495 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20974715 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17642144 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.14911864 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.11058817 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10919402 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.10397658 |
| 30 | RNA degradation_Homo sapiens_hsa03018 | 1.09727245 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.09075528 |
| 32 | Basal transcription factors_Homo sapiens_hsa03022 | 1.06527649 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.05871811 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05503013 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05403453 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02694391 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01801056 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00726191 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99723304 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99240775 |
| 41 | RNA transport_Homo sapiens_hsa03013 | 0.99076219 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98677325 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.97974633 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97898486 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97028204 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96834992 |
| 47 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96365822 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 0.95782355 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92881768 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91599385 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90247999 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89475494 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89447394 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88782196 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.88574280 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87334941 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87315104 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85511406 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85471586 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83391914 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82979627 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81228556 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80050153 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79816208 |
| 65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.79641304 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78733956 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77457524 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.76395889 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75725592 |
| 70 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75410000 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75307162 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75229461 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74942588 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.74202758 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73135893 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73003552 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72513101 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72447884 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67240500 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65540285 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61470642 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61338542 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59832471 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59428038 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59254807 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58805518 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.57937739 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.57198426 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57119977 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56509452 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56162006 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54336142 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52455250 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.51142174 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49764153 |
| 96 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48993083 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48904697 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.48726562 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48239786 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46565913 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45748622 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44261499 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43998788 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.42809039 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41277475 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41010307 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40955645 |
| 108 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40653215 |
| 109 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.40373402 |
| 110 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39852311 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39431820 |
| 112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39352948 |
| 113 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38482710 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38166518 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37684883 |
| 116 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36211365 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35553170 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34320457 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34261792 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33115521 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32479345 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28369610 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27784011 |
| 124 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.25137187 |
| 125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.24968203 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.23982189 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.21919500 |

